Finance News – Astrazeneca
What is your interest today?
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
Investors fret on talk of AstraZeneca US move
Concerns have grown among shareholders about the potential impact on the UK market and investment stability if AstraZeneca relocates its operations to the United States.
Read Full Article →If AstraZeneca goes to the US, it will be a major blow for London and Labour
Relocating AstraZeneca's headquarters to the United States could significantly impact London’s financial markets and challenge the stability of current government plans supporting...
Read Full Article →Losing AstraZeneca would be more than a bitter pill for the City – it could be fatal
The potential departure of AstraZeneca from the London Stock Exchange poses a serious financial threat, highlighting the need for government reforms to maintain the market’s compet...
Read Full Article →AstraZeneca boss ‘wants to shift stock market listing to US’
The potential relocation of AstraZeneca’s equity listing to the United States could impact investor access, market perception, and the company’s regulatory and financial reporting...
Read Full Article →Astrazeneca chief ‘wants to shift London listing to US’
Relocating the company’s stock exchange registration to the United States could potentially enhance access to larger capital markets and increase investor exposure for the pharmace...
Read Full Article →Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting close...
Pharmaceutical companies are advancing the development of specialized cancer treatments, potentially reducing reliance on chemotherapy and driving significant market growth through...
Read Full Article →FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca
Merck’s newly authorized RSV vaccine for infants is expected to impact the market by challenging established treatments, potentially influencing sales and market share among leadin...
Read Full Article →GSK and Astrazeneca shares slump as Trump vows drug price cut
The announcement of new executive measures aimed at lowering medication costs has led to a decline in the stock values of major pharmaceutical companies, reflecting investor concer...
Read Full Article →FTSE 100’s record run fades as pharma stocks slide on new Trump appointment
The decline in major pharmaceutical shares contributed to a modest drop in the FTSE 100, signaling potential market uncertainty linked to changes in US regulatory leadership.
Read Full Article →